NCT05572749View on ClinicalTrials.gov

Clinical Trial of Crocus Kozanis Administration in Obese Children and Adolescents

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
PreDiabetesObesityDyslipidemias
Interventions
DIETARY_SUPPLEMENT

Crocus Kozanis

In this study, intervention will be the administration of Crocus Kozanis dietary supplement. Crocus Kozanis is a herb which is cultivated in Kozani, Greece.

DIETARY_SUPPLEMENT

Placebo of Crocus Kozanis

Placebo of Crocus Kozanis

DRUG

Metformin

Metformin will be administered in a dosage of 1000mg per day. Metformin is a formally approved therapy for children with diabetes in Europe.

Trial Locations (1)

Unknown

Unit of Paediatric Endocrinology and Metabolism, 2nd Department of Paediatrics, AHEPA University Hospital, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER